Business Description
Cytori Cell Research Institute Inc
ISIN : JP3426500009
Description
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 1.02 | |||||
| Debt-to-EBITDA | -2.77 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.21 | |||||
| Beneish M-Score | -2.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.9 | |||||
| 3-Year EBITDA Growth Rate | -28.1 | |||||
| 3-Year EPS without NRI Growth Rate | 45.2 | |||||
| 3-Year FCF Growth Rate | -121 | |||||
| 3-Year Book Growth Rate | -8.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.36 | |||||
| 9-Day RSI | 45.24 | |||||
| 14-Day RSI | 46.2 | |||||
| 6-1 Month Momentum % | -12.51 | |||||
| 12-1 Month Momentum % | -23.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 1.48 | |||||
| Days Inventory | 177.93 | |||||
| Days Sales Outstanding | 17.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | 54.99 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.84 | |||||
| Operating Margin % | -49.52 | |||||
| Net Margin % | 8.85 | |||||
| FCF Margin % | -74.88 | |||||
| ROE % | 5.85 | |||||
| ROA % | 1.44 | |||||
| ROIC % | 1.11 | |||||
| ROC (Joel Greenblatt) % | -12.32 | |||||
| ROCE % | -10.13 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 54.53 | |||||
| PS Ratio | 4.82 | |||||
| PB Ratio | 3.22 | |||||
| Price-to-Tangible-Book | 3.24 | |||||
| EV-to-EBIT | -10.94 | |||||
| EV-to-EBITDA | -10.94 | |||||
| EV-to-Revenue | 6.01 | |||||
| EV-to-FCF | -8.05 | |||||
| Price-to-Median-PS-Value | 2.24 | |||||
| Earnings Yield (Greenblatt) % | -9.15 | |||||
| FCF Yield % | -15.53 | |||||
| Forward Rate of Return (Yacktman) % | -50 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cytori Cell Research Institute Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 1,560.388 | ||
| EPS (TTM) (円) | 15.461 | ||
| Beta | -0.02 | ||
| Volatility % | 18.33 | ||
| 14-Day RSI | 46.2 | ||
| 14-Day ATR (円) | 27.14536 | ||
| 20-Day SMA (円) | 859.45 | ||
| 12-1 Month Momentum % | -23.92 | ||
| 52-Week Range (円) | 777 - 1168 | ||
| Shares Outstanding (Mil) | 8.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cytori Cell Research Institute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cytori Cell Research Institute Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cytori Cell Research Institute Inc Frequently Asked Questions
What is Cytori Cell Research Institute Inc(TSE:3750)'s stock price today?
The current price of TSE:3750 is 円843.00. The 52 week high of TSE:3750 is 円1168.00 and 52 week low is 円777.00.
When is next earnings date of Cytori Cell Research Institute Inc(TSE:3750)?
The next earnings date of Cytori Cell Research Institute Inc(TSE:3750) is .
Does Cytori Cell Research Institute Inc(TSE:3750) pay dividends? If so, how much?
Cytori Cell Research Institute Inc(TSE:3750) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers